Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2001
10/09/2001US6300099 Methods for producing secreted ligand-binding fusion proteins
10/09/2001US6300097 A polypeptide; therapy and diagnosis of bacterial infections; upper respiratory infections, toxic shock syndrome, septic arthritis and intestinal disorders
10/09/2001US6300096 Polynucleotides encoding fatty acid transport proteins
10/09/2001US6300095 A dna fragment used for blocking genetic expression through antisense constructs and for increased antibiotic production
10/09/2001US6300094 Polynucleotides encoding a novel ABC transporter
10/09/2001US6300093 Islet cell antigen 1851
10/09/2001US6300092 Methods of use of a novel lysyl oxidase-related protein
10/09/2001US6300090 Delivering antigens to proliferating and non-proliferating dendritic cells using a nonreplicating influenza viral vector; the dentritic cells will process and express the antigen which will then activate cd8 cytotoxic t lymphocytes
10/09/2001US6300089 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
10/09/2001US6300087 A screening method to determine drugs that bind to human serotonin receptors by exposing nonneuronal cells expressing the serotonin receptor on their surface with a plurality of drugs; determine which drugs interact by binding
10/09/2001US6300086 Transform cells with polynucleotides encoding ligand protein and domain proteins with a reporter gene whose expression is regulated by ligands binding the domain protein; culture cells with/without agent, measure expression based on binding
10/09/2001US6300076 Diagnostic detecting method of target nucleic acid in biological sample by amplifying nucleic acid, ionizing and volatilizing the product then analyze nucleic acid by mass spectrometry to detect presence of nucleic acid in the sample
10/09/2001US6300075 Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
10/09/2001US6300074 Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
10/09/2001US6300070 A multi-stage bridge amplification method using a recovered single stranded amplified nucleic acid molecule to intiate additional stages of bridged amplification
10/09/2001US6300069 Generation and amplification of nucleic acids from ribonucleic acids
10/09/2001US6300068 Nucleic acid assays
10/09/2001US6300067 TFIIB transcription factor from Candida albicans and methods of screening for inhibitors of Candida albicans growth
10/09/2001US6300065 Anchoring polypeptides to yeast cell wall accesible for protein-protein binding along with fluorescence activated cell sorting for selecting cells exhibiting a variegated population of mutant proteins
10/09/2001US6300064 Protein/(poly)peptide libraries
10/09/2001US6300061 Screening drug susceptibilities of mycobacterial lysogens by using a luciferase reporter mycobacteriophage incubated with clinical samples, expressing the reporter gene if the sample contains the mycobacteria, diagnosing mycobacterial infection
10/09/2001US6300059 Testing tissue sample to determime the expression levels of mrna or protein encoded by a p53 mediator, waf1, and compare values to normal tissue; diagnosis and therapy of human tumors, cancer therapy
10/09/2001US6300058 Immobilize a polynucleotide to an insoluble support, allow hybridization to a unique mrna sequence, apply a second probe to the support that hybridizes to a second sequence of the mrna, measure immobilization to quantitate mrna
10/09/2001US6300056 A synthetic oligonulceotide having one segment homologous with a segment of hiv nucleic acid and a second segment of a nucleotide sequence which is homologous to an oligonucleotide segment of a nucleic acid multimer not complementary to hiv
10/09/2001US6299883 Tarf
10/09/2001US6299882 UL54.5 of Marek's disease virus (MDV)
10/09/2001US6299877 Used in therapy
10/09/2001US6299876 Cytotoxic drug therapy
10/09/2001US6299870 Has antiviral activity, antitumor activity, growth inhibition activity and immunosupressive activity; used in therapy
10/09/2001US6299869 Human interferon-epsilon: a type I interferon
10/09/2001US6299858 Contacting living teleost post 12-hours of development with dye having affinity for dead cells and stains dead cells; administering agent to living teleost; detecting staining of dead cells with dye in specific tissue or organ; comparing
10/09/2001CA2240289C Soaps produced from high laurate canola oil-based fatty acids
10/09/2001CA2235025C Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis
10/09/2001CA2220270C Method for reducing inhibitors of nucleic acid hybridization
10/09/2001CA2179656C Chromosomal expression of heterologous genes in bacterial cells
10/09/2001CA1341302C Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein
10/09/2001CA1341301C Preparation of functional human urokinase proteins
10/09/2001CA1341300C Recombinant dna means and method for producing bovine rennin and precursors
10/07/2001CA2340936A1 Inhibitors for the formation of soluble human cd23
10/05/2001CA2340300A1 Nucleotide sequences that code for the rplk gene and methods of use thereof
10/04/2001WO2001073439A1 Docosahexaenoic acid as retinoid x receptor and uses thereof
10/04/2001WO2001073432A2 Method for detecting and/or quantifying first molecules
10/04/2001WO2001073428A1 Method and system for clustering data
10/04/2001WO2001073133A1 Compositions and methods for identifying and targeting cancer cells
10/04/2001WO2001073132A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/04/2001WO2001073131A1 High specificity marker detection
10/04/2001WO2001073127A2 Improved invasion assay
10/04/2001WO2001073123A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
10/04/2001WO2001073118A2 Hybridisation beacon and method of rapid sequence detection and discrimination
10/04/2001WO2001073117A1 Use of particles which have signal-emitting characteristics and at least one group with an affinity for marked nucleic acids
10/04/2001WO2001073115A1 Method and kit for the screening, the detection and/or the quantification of transcriptional factors
10/04/2001WO2001073108A2 A bacterial two-hybrid system for protein interaction screening
10/04/2001WO2001073107A1 Prion-free transgenic ungulates
10/04/2001WO2001073105A1 Mammalian two-hybrid system
10/04/2001WO2001073101A1 Process for producing amide compounds
10/04/2001WO2001073094A2 Novel sperm-dna complexes for genetically modifying non-human animals
10/04/2001WO2001073093A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site
10/04/2001WO2001073092A2 Interspecific dianthus plant
10/04/2001WO2001073091A2 Methods of selection and development of plants having improved root quality and root lodging resistance
10/04/2001WO2001073090A2 Method for modifying lignin composition and increasing in vivo digestibility of forages
10/04/2001WO2001073089A1 Control of aerial branching
10/04/2001WO2001073088A1 Sequence regulating the anther-specific expression of a gene and its use in the production of androsterile plants and hybrid seeds
10/04/2001WO2001073087A1 Cestrum yellow leaf curling virus promoters
10/04/2001WO2001073086A2 Method for genetically modifying a plant
10/04/2001WO2001073085A1 Expression vectors for concentrating a recombinantly produced protein in different cell compartments
10/04/2001WO2001073084A2 Methods for rapidly producing transgenic monocotyledonous plants
10/04/2001WO2001073083A2 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use
10/04/2001WO2001073082A2 Methods and cells for expression of recombinant protein products
10/04/2001WO2001073081A1 Escherichia coli strain secreting human granulocyte colony stimulating factor (g-csf)
10/04/2001WO2001073080A2 Recombinant iron uptake proteins
10/04/2001WO2001073078A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide
10/04/2001WO2001073077A2 Regulation of human serine racemase enzyme
10/04/2001WO2001073076A2 Helicase inhibitors
10/04/2001WO2001073075A2 Muskmelon cucumis melo hydroperoxide lyase and uses thereof
10/04/2001WO2001073074A2 18806, a novel trypsin serine protease-like molecule and uses thereof
10/04/2001WO2001073073A2 Regulation of human neutral protease-related enzyme
10/04/2001WO2001073072A1 Novel polypeptide--- a human molecular chaperone 18 and polynucleotide encoding it
10/04/2001WO2001073071A1 Novel polypeptide--- a human aldehyde/ketone reductase 10 and polynucleotide encoding it
10/04/2001WO2001073070A1 Novel polypeptide--- a rjs related protein 94 and polynucleotide encoding it
10/04/2001WO2001073069A1 Novel polypeptide-a human tumor related nucleoprotein 12 and polynucleotide encoding it
10/04/2001WO2001073068A1 Novel polypeptide - a line 1-12 and polynucleotide encoding it
10/04/2001WO2001073067A1 Novel polypeptide --- a human formin protein 12 and polynucleotide encoding it
10/04/2001WO2001073066A1 A novel polypeptide, a human atp dependent serine hydrolase 10.1 and the polynucleotide encoding the polypeptide
10/04/2001WO2001073065A1 Novel polypeptide--- a human ribose phosphate glycine amide synthetase 12 and polynucleotide encoding it
10/04/2001WO2001073064A1 Novel polypeptide, a microtubulin helper factor 9 and polynucleotide encoding it
10/04/2001WO2001073063A1 Novel polypeptide---a human hexose kinase 13 and polynucleotide encoding it
10/04/2001WO2001073062A1 Novel polypeptide--- a prostate specific membrane antigen 18 and polynucleotide encoding it
10/04/2001WO2001073061A1 Novel polypeptide - a human retinoblastoma protein 22 and polynucleotide encoding it
10/04/2001WO2001073060A2 18221, dual specificity phosphatase and uses thereof
10/04/2001WO2001073059A2 38692 and 21117: dual specificity phosphatase molecules and uses therefor
10/04/2001WO2001073058A2 33338, a novel human ubiquitin hydrolase-like molecule and uses thereof
10/04/2001WO2001073057A1 19053, a novel atpase-like molecule and uses thereof
10/04/2001WO2001073056A2 Regulation of human oxoprolinase-like enzyme
10/04/2001WO2001073055A1 A novel polypeptide, a human phosphatidic acid phosphatase 2-12 and the polynucleotide encoding the polypeptide
10/04/2001WO2001073054A1 A novel polypeptide, a human dihydroorotase 11 and the polynucleotide encoding the polypeptide
10/04/2001WO2001073053A1 A novel polypeptide-human phospholipase 13 and the polynucleotide encoding said polypeptide
10/04/2001WO2001073052A2 Thermophilic polymerase iii holoenzyme
10/04/2001WO2001073051A2 46743 and 27417, novel human acyltransferase family members and uses therefor
10/04/2001WO2001073050A2 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
10/04/2001WO2001073049A2 33877 and 47179, human glycosyl transferase family members and uses thereof